Login
Toggle navigation
Videos
Categories
Trending
Steven van Rijswijk, CEO of ING, discusses global business and market trends in an interview with CNBC at the World Economic Forum.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Steven van Rijswijk, CEO of ING
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Leon Black Reflects on Building Apollo and the Future of Private Equity | Leon Black, Chairman and CEO, Apollo Global Management.
00:10:00
Navigating Change: A CEO Reflects on Earnings and Future Growth Strategies
00:10:00
The Impact of Digital Convergence, Cybersecurity, and Long-term Vision on Modern Business Practices
00:10:00
Targeting the Lost Generation: Bridging the Age Gap in Broadcasting | Karl Thedéen , CEO of Edgeware AB
00:10:00
Fabrício Mitre Discusses Real Estate Market Trends and Sector Results at Mitre Realty | Fabrício Mitre, CEO , Mitre Realty Empreendimentos e Participações SA.
00:10:00
Japan's Semiconductor Sector: A Strategic Analysis and Outlook | Masa Takeda, Portfolio Manager, SPARX Group.
00:10:00
Aims to open VC funding to tenacious and ambitious female founders|Jennifer Keiser Neundorfer,Co-Founder and Managing Partner,January Ventures
00:10:00
Rover Metals: Advancing Lithium, Zinc, and Copper Projects in Northern Canada and Nevada
00:10:00
Thys van Zyl of Everest Wealth Management Discusses Cryptocurrency Dynamics | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
House Majority Leader Kevin McCarthy: Roles and Responsibilities|Peter Robinson
00:10:00
Financial Venture model is little bit different|Tyler Griffin,Managing Partner,Restive Ventures
00:10:00
Pioneering Japanese CEO's Vision for Personal Health and Preventative Medicine | Kazuo Nakamura, CEO, CMIC Holdings Co Ltd.